✦ LIBER ✦

Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer

✍ Scribed by Epelbaum, Ron; Schaffer, Moshe; Vizel, Bella; Badmaev, Vladimir; Bar-Sela, Gil

Book ID: 118743134
Publisher: Lawrence Erlbaum Associates, Inc.
Year: 2010
Tongue: English
Weight: 94 KB
Volume: 62
Category: Article
ISSN: 0163-5581
DOI: 10.1080/01635581.2010.513802

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine–radiotherapy in patients wit

Gemcitabine–radiotherapy in patients with locally advanced pancreatic cancer

✍ S.M. de Lange; C.J. van Groeningen; O.W.M. Meijer; M.A. Cuesta; J.A. Langendijk; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II Trial of Curcumin in Patients w

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

✍ Dhillon, N.; Aggarwal, B. B.; Newman, R. A.; Wolff, R. A.; Kunnumakkara, A. B.; 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 661 KB

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced pancreatic cancer

✍ Camichael, J.; Fink, U.; Russell, R.C.G.; Spittie, M.F.; Harris, A.; Spiessi, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Palliative pancreatectomy with postopera

Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer

✍ Yasuhiro Fujino; Tetsuya Sakai; Yoshikazu Kuroda 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 194 KB

A pharmacological study of celecoxib and

A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer

✍ Henry Q. Xiong; William Plunkett; Robert Wolff; Min Du; Renato Lenzi; James L. A 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 223 KB

A pharmacological study of celecoxib and

A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer

✍ Henry Q. Xiong; William Plunkett; Robert Wolff; Min Du; Renato Lenzi; James L. A 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 223 KB

## Purpose: To evaluate whether celecoxib alters the conversion of gemcitabine into its active metabolite, difluorodeoxycytidine triphosphate (dfdctp), in peripheral blood mononuclear cells (pbmcs). ## Methods: Patients with advanced pancreatic cancer who had not received chemotherapy and had acc